...
机译:印度乳腺癌人群中前哨淋巴结阳性患者非前哨淋巴结受累的影响因素和MSKCC线型图的验证
Department of Surgery and Surgical Oncology Apollo Speciality Hospitals">(1);
Department of Surgery and Surgical Oncology Apollo Speciality Hospitals">(1);
Department of Surgery and Surgical Oncology Apollo Speciality Hospitals">(1);
Department of Pathology Apollo Speciality Hospitals">(2);
Department of Surgery and Surgical Oncology Apollo Speciality Hospitals">(1);
Breast surgery Chennai Breast Centre">(3);
Breast cancer; Sentinel node positive; Non-sentinel node metastasis; MSKCC nomogram;
机译:影响非Sentinel节点参与的因素在Sentinel节点阳性患者中参与并验证印度乳腺癌人口中的MSKCC Nom图
机译:前哨淋巴结活检阳性的乳腺癌患者的诺模图预测非前哨淋巴结转移风险的验证:MSKCC乳房诺模图的验证。
机译:线型图验证可预测前哨淋巴结活检阳性的乳腺癌患者发生非前哨淋巴结转移的风险:MSKCC乳房线型图的验证
机译:乳腺MRI辐射射清,用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
机译:在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
机译:印度乳腺癌人群中前哨淋巴结阳性患者非前哨淋巴结受累的影响因素和MSKCC线型图的验证
机译:纪念斯隆-凯特琳癌症中心列阵图在前哨淋巴结阳性乳腺癌患者中非前哨淋巴结转移预测中的有效性国际比较